State of the art in CAR T cell therapy for CD19+ B cell malignancies is a research paper published in Journal of Clinical Investigation (2020). On theSindex it has a DataRank of 0. It has been cited 105 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: K12 CA087723
National Institutes of Health
Grant: 5K12CA087723-23
Dana Farber/Harvard Cancer Consortium Career Development Program in Clinical Oncology
FWCI
5.77
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals